Search Results - "Isaji, Masayuki"

Refine Results
  1. 1

    SGLT2 inhibitors: molecular design and potential differences in effect by Isaji, Masayuki

    Published in Kidney international (01-03-2011)
    “…The physiological and pathological handling of glucose via sodium–glucose cotransporter-2 (SGLT2) in the kidneys has been evolving, and SGLT2 inhibitors have…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Mizagliflozin, a novel selective SGLT1 inhibitor, exhibits potential in the amelioration of chronic constipation by Inoue, Toshihiro, Takemura, Masaaki, Fushimi, Nobuhiko, Fujimori, Yoshikazu, Onozato, Tomoya, Kurooka, Takao, Asari, Tetsuya, Takeda, Hiroo, Kobayashi, Mamoru, Nishibe, Hironori, Isaji, Masayuki

    Published in European journal of pharmacology (05-07-2017)
    “…Chronic constipation is a highly common functional gastrointestinal disorder that adversely affects patient quality of life. At present, limited therapeutic…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Sergliflozin etabonate, a selective SGLT2 inhibitor, improves glycemic control in streptozotocin-induced diabetic rats and Zucker fatty rats by Fujimori, Yoshikazu, Katsuno, Kenji, Ojima, Kazuma, Nakashima, Ikumi, Nakano, Shigeru, Ishikawa-Takemura, Yukiko, Kusama, Hiroshi, Isaji, Masayuki

    Published in European journal of pharmacology (01-05-2009)
    “…The low-affinity sodium glucose cotransporter (SGLT2) is responsible for most of the glucose reabsorption in the kidney and has been highlighted as a novel…”
    Get full text
    Journal Article
  8. 8

    Identification of 8‑Aminoadenosine Derivatives as a New Class of Human Concentrative Nucleoside Transporter 2 Inhibitors by Tatani, Kazuya, Hiratochi, Masahiro, Nonaka, Yoshinori, Isaji, Masayuki, Shuto, Satoshi

    Published in ACS medicinal chemistry letters (12-03-2015)
    “…Purine-rich foods have long been suspected as a major cause of hyperuricemia. We hypothesized that inhibition of human concentrative nucleoside transporter 2…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Physiological difference between obese (fa/fa) Zucker rats and lean Zucker rats concerning adiponectin by Oana, Fumiki, Takeda, Hiroo, Hayakawa, Kohichi, Matsuzawa, Akane, Akahane, Satoshi, Isaji, Masayuki, Akahane, Masuo

    Published in Metabolism, clinical and experimental (01-08-2005)
    “…Obese (fa/fa) Zucker rat is a spontaneous genetic obesity model and, by comparison with lean Zucker rat, exhibits hyperphagia, hyperinsulinemia, and…”
    Get full text
    Journal Article
  11. 11

    Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo by Isaji, Masayuki, Miyata, Hiroshi, Ajisawa, Yoshiyuki, Takehana, Yasuo, Yoshimura, Nagahisa

    Published in British journal of pharmacology (01-11-1997)
    “…1 First developed as an antiallergic drug, tranilast inhibits chemical mediator release from mast cells. In the present study, we examine the effects of…”
    Get full text
    Journal Article
  12. 12

    Sodium-glucose cotransporter inhibitors for diabetes by Isaji, Masayuki

    “…In the search for potential new drug targets for the treatment of diabetes, sodium-glucose cotransporters (SGLTs), in particular SGLT2, have been the subject…”
    Get more information
    Journal Article
  13. 13

    Rat model of the hypercalcaemia induced by parathyroid hormone-related protein: characteristics of three bisphosphonates by Komatsu, Yoshimitsu, Imai, Yohsuke, Itoh, Fumiaki, Kojima, Masami, Isaji, Masayuki, Shibata, Nobuo

    Published in European journal of pharmacology (10-01-2005)
    “…In our preliminary experiment, we found that a constant infusion of a high dose of parathyroid hormone-related protein induced both hyperphosphataemia and…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male Mice by Nakano, Shigeru, Katsuno, Kenji, Isaji, Masayuki, Nagasawa, Tatsuya, Buehrer, Benjamin, Walker, Susan, Wilkison, William O, Cheatham, Bentley

    “…Background Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis (NASH) are serious conditions and are being diagnosed at an increased rate. The…”
    Get full text
    Journal Article
  16. 16

    Inhibitory Effects of Tranilast on the Proliferation and Functions of Human Pterygium-derived Fibroblasts by Isaji, Masayuki, Kikuchi, Shinji, Miyata, Hiroshi, Ajisawa, Yukiyoshi, Araki-Inazawa, Kaori, Tsukamoto, Yuji, Amano, Yoshinari

    Published in Cornea (01-05-2000)
    “…PURPOSE.We studied the possibility that tranilast, an antiallergic and antiproliferative drug, may be beneficial for the treatment of pterygium…”
    Get full text
    Journal Article
  17. 17

    Inhibition by tranilast of vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF)-induced increase in vascular permeability in rats by Isaji, Masayuki, Miyata, Hiroshi, Ajisawa, Yukiyoshi, Yoshimura, Nagahisa

    Published in Life sciences (1973) (1998)
    “…We studied the effects of tranilast, an anti-allergic and anti-proliferative drug in clinical use, on VEGF/VPF-induced vascular permeability in a rat air pouch…”
    Get full text
    Journal Article
  18. 18

    Long-term treatment with sergliflozin etabonate improves disturbed glucose metabolism in KK-A(y) mice by Katsuno, Kenji, Fujimori, Yoshikazu, Ishikawa-Takemura, Yukiko, Isaji, Masayuki

    Published in European journal of pharmacology (15-09-2009)
    “…Sergliflozin etabonate, a novel oral selective low-affinity sodium glucose cotransporter (SGLT2) inhibitor, improves hyperglycemia by suppressing renal glucose…”
    Get full text
    Journal Article
  19. 19

    Hypouricemic effects of novel concentrative nucleoside transporter 2 inhibitors through suppressing intestinal absorption of purine nucleosides by Hiratochi, Masahiro, Tatani, Kazuya, Shimizu, Kazuo, Kuramochi, Yu, Kikuchi, Norihiko, Kamada, Noboru, Itoh, Fumiaki, Isaji, Masayuki

    Published in European journal of pharmacology (05-09-2012)
    “…We have developed concentrative nucleoside transporter 2 (CNT2) inhibitors as a novel pharmacological approach for improving hyperuricemia by inhibiting…”
    Get full text
    Journal Article
  20. 20

    Crystal structures of the Apo and Holo form of rat catechol-O-methyltransferase by Tsuji, Eiichi, Okazaki, Kosuke, Isaji, Masayuki, Takeda, Kei

    Published in Journal of structural biology (01-03-2009)
    “…Catechol-O-methyltransferase (COMT, EC 2.1.1.6) is a monomeric enzyme that catalyzes the transfer of a methyl group from S-adenosyl-l-methionine (AdoMet) to…”
    Get full text
    Journal Article